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SUMMARY 
Telemedicine systems can play an important role in the 
management of diabetes, a chronic condition that is 
increasing worldwide. Evaluations on the consistency of 
information across these systems and on their performance 
in a real situation are still missing. This paper presents a 
remote monitoring system for diabetes management based 
on physiological sensors, mobile technologies and 
patient/doctor applications over a service oriented 
architecture that has been evaluated in an international trial 
(83905 operation records). The proposed system integrates 
three types of running environments and data engines in a 
single service oriented architecture. This feature is used to 
assess key performance indicators comparing them with 
other type of architectures. Data sustainability across the 
applications has been evaluated showing better outcomes 
for full integrated sensors.  At the same time, runtime 
performance of clients has been assessed spotting no 
differences regarding the operative environment. 
1 INTRODUCTION 
Diabetes is defined as a set of syndromes where 
high blood glucose levels are the common 
factor. Inefficiency or absence of endogen 
insulin leads to metabolic disorders which cause 
micro and macro vascular complications in both 
short and long term [1]. A good quality of life, 
together with an adequate adherence to the 
medical treatment can delay the rise of 
complications [2]. 
The management of this disease has improved 
with the arrival of new monitoring systems, 
insulin pumps and oral drugs. From the 
handmade logbook reporting to stem-cells 
research, a wide variety of medical technologies 
are applied to maintain patient health. The 
healthcare industry and academics are fostering 
improvements in monitoring technologies: 
recently, the accuracy and reliability of a fiber-
coupled optical continuous glucose sensor was 
tested for 14 consecutive days in a clinical trial, 
showing promising results [3]; closed-loop 
artificial pancreas [4] can significantly reduce 
glucose variability, regardless patient adherence 
to treatment. Nevertheless, the patient should 
not be taken out of the equation. A recent study 
evaluated the capability of 25 diabetic patients 
to adjust the subcutaneous insulin infusion 
therapy and avoid glycemic excursions, proving 
that an information management system can 
improved glycemic control by performing 
accurate adjustments to the insulin delivery [5]. 
While the literature is progressively focusing on 
the cost-effectiveness of applying new 
technologies to diabetes management [6] [7], 
the focus should be on promoting patient 
education and consciousness to deal with the 
disease. In the case of non-communicable 
diseases, where long duration and slow 
progression require concrete actions on patient 
lifestyle, the Information and Communication 
Technologies (ICT) may contribute to provide 
the individual and  supporting careers with 
solutions to manage therapies, increase 
awareness and promote healthy self-
management habits [7] [8].  
One of the purposes of remote monitoring in 
diabetes is to prevent a worsening condition and 
hospitalization due to long-period 
hyperglycemias and decompensation by 
providing patient data to care providers [9], 
which may also lead to reducing the high 
economic health costs [6]. Besides educational 
and telephone aid, patient self-management 
support may be augmented by using home-
based technologies that generate data points 
which providers can potentially use to make 
more timely changes in the patients' care. The 
effectiveness of a secure e-mail attention 
program in diabetic population has been 
demonstrated [10], nevertheless authors point 
out the need for embedding such 
communication channels within a continuous 
self-management system.  
ICT solutions are presented as key solutions for 
managing diabetes [11]. First interventions used 
the Internet and Public Switched Telephone 
Network in urban and rural environments [12] 
[13]. Later on, mobile networks based on GPRS 
[4] [14] [15] and internet portals [16] [17] were 
used as new paradigms of the application of ICT 
in diabetes management. More recently 
comparative frameworks [18] have described 
the benefits of using mobile technologies in the 
management of chronic conditions and other 
authors have suggested the implementation of 
new communication architectures based on 
services (SOA) [19].  
The impact of telemedicine interventions is 
highly dependent on the architecture and 
performance of the system. The variety of 
results achieved in the literature [20] could be 
better understood by contextualizing each 
intervention in terms of system implementation 
and performance. There are qualitative and 
quantitative tools to measure the user response 
to a single tool or system [21], however, the 
technical implementation and evaluation should 
be presented to add significance to the results of 
a telemedicine intervention. The performance 
should be assessed using specific benchmarks, 
known as Key Performance Indicators (KPI), 
that describe the quality of service. Typical 
examples of KPIs include cost, security, 
reliability, and delays. 
The rationale of this paper is to present a new 
system for diabetes remote monitoring oriented 
to patient self-management based on a SOA and 
to introduce a technical assessment of the 
system performance in a trial with 30 type 1 and 
2 diabetes patients and up to 83905 interaction 
records. The system uses home and portable 
devices for monitoring blood glucose, physical 
activity, weight, blood pressure and applications 
to record data (food intake, medication, 
educational level and lifestyle). Unlike the 
related work, the insulin pump device is 
discarded as the patient himself is the booster of 
the treatment (according to doctor’s guidelines). 
The presented SOA is based on internet protocol 
communication which merges different 
operative systems and software environments 
(Windows Mobile, iOS, Apache Tomcat and 
.NET) and is evaluated using existing KPIs 
under specific domains [22]. Clinical and 
usability assessments are out of the scope of this 
research work. Records of data, synchronization 
logs and services invocations have been 
analyzed to evaluate the effectiveness of the 
proposed solution from a performance and data 
aggregation perspective. 
2 METHODS 
The architecture of the telemonitoring system 
consists of three main blocks, shown in Figure 
1. In the bottom square: patient devices with 
mobile and desktop applications to retrieve data 
from sensors and to self-manage the disease by 
recording events, reading prescriptions from the 
doctor side and showing historic trends. Top 
right the Control Panel (CP), from which 
healthcare professionals are able to supervise 
patient evolution, prescribe treatments and 
modify therapies. And top left the system 
central server where all the communicating 
functionalities and intelligent modules are 
hosted to provide a user-blinded closed-loop 
solution to all users: both patients and care 
providers.  
 
Figure 1. System schema combining the components 
devoted for patients, doctors and server. Sensors are 
connected to the Patient Panel through the interfaces 
depicted in Section 2.2. All the communications are held by 
the Internet Protocol.  
Single features for each type of user were 
translated into requirements and then deployed 
as tools to run over multiple platforms (Figure 
1). This process was made under User Centered 
Design (UCD) techniques [23]. These tools 
were developed within Application Program 
Interfaces (APIs) and scaled to provide multiple 
levels of interactions, depending on the type of 
diabetes and the type of user. The information 
generated was sent via web services to 
healthcare professionals involved in the follow 
up process. Two Patient Mobile Devices (PMD) 
contained native applications to record and 
display prescriptions fixed by the doctor in the 
CP, trends from sensor and lifestyle variables 
(food intake and medication) and educational 
material. T1DM patients were provided with a 
HTC (WM 6.1) and T2DM an iPhone 3G (iOS 
4.2.1). Patient Panel (PP) was a table/desktop 
application that both type of users were able to 
use to download sensor data (sensor platform is 
further detailed in point 2.4) from each device 
and upload it to the system server so it was 
accessible to both the physicians application and 
the patient mobile application. 
2.1 Service Oriented Architecture 
The main technical challenge consisted in 
storing this kind of information in a common 
Personal Health Record (PHR), enabling 
different interaction from all the modules within 
the system. Client applications (patient and 
doctor) are connected through a distributed 
SOA which contains a central data base and 
surrounding modules to build up a secure and 
scalable platform of functionalities for data 
analysis and exchange.  
 
Figure 2. System architecture is built up by three layers 
connecting different technologies through a web service 
implementation.  
Up to seven modules were in charge of 
administrating the central data base, performing 
data analysis, controlling patient compliance 
and treatment follow up awareness in terms of 
the uploaded data. This approach was designed 
to provide consistent security features (access 
and integrity) at the same time to all data 
entities.  
To meet system requirements in the architecture 
drawn in Figure 2, web services were developed 
to be invoked from different technologies 
through a combination of SOAP/XML and 
WSLD protocols. A total of forty-five methods 
were designed, implemented and tested. 
Information was embedded into XML files and 
sent as serialized or compact objects depending 
on the connection speed rate.  
Different client applications (iOS, .NET, java) 
are integrated in this platform using several data 
engines (SQLite, SQLCE, MySQL). Despite the 
similar data type definitions for these 
technologies, many troubles were found in the 
integration of some data-types (mostly related to 
the number of bytes contained Integer and Float 
values). Thus, all services were developed to 
work with the common data type across 
mentioned platform (32 byte string), and then 
convert the value locally depending on the type 
of client implementation. 
2.2 Sustainable Data Management and 
Storage 
Several approaches to support easy information 
acquisition have been developed to guarantee 
sustainable data storage. Giving the user the 
right information at the right moment may 
enable patients to achieve better results on 
health indicators. 
To maintain data integrity and keep a stable 
PHR synchronization among components, an 
ad-hoc acknowledgment protocol based on 
global unique identifiers was developed. To be 
able to use communication services, each 
application had to be registered prior to normal 
service requests. The registration process 
consisted in providing the patient with a 
username and a password to log into the 
application. If credentials matched, the 
application was registered into the server and 
services enabled to start exchanging sensitive 
information only to that unique patient device. 
Subsequent access to the application was made 
possible by inputting a personal identification 
number (configurable by patients). 
Within the mentioned services, a set of three 
services were developed to deal with sensor 
data. Sensor synchronization was designed to 
occur in a wide variety of time intervals. 
Against plain-text information wrapped into 
XMLs, sensor data was sorted into a custom 
format vector to avoid service overloads 
(headers and identifiers repeated for each 
measurement). For instance, Continuous 
Glucose Monitoring System (CGMS) data 
recorded during two weeks could be uploaded at 
once containing more than four thousand 
measurements as well as pedometer data 
corresponding to one day, containing twenty-
four values. 
Table 1. Medical sensors within the platform sorted by the 
group to which they belong depending on the data access 
protocol. 
Different types of information acquired from 
several data sources had to be stored in a 
homogeneous database. ISO 11073 data 
ID Sensor Group 
1 Medtronic GuardianRT ® CGMS 2 
2 Bayer TM Contour-Link Glucometer 2 
3 SenseWear ArmBand – Physical 
Activity Sensor 
2 
4 OMRON HJ-720IT Pedometer 1 
5 OMRON MT-10T Blood pressure 1 
6 AANDD Weight Scale 3 
structure standard was used to classify values 
read from the sensors through an Application 
Program Interface (API) [27]. The deployed 
API merged functionalities to hold 
communications through physical interfaces 
(Group 1: USB, Group 2: virtual sensors, using 
proprietary protocol and providing CSV reports, 
Group 3: Bluetooth) and logical channels, 
deploying the communication protocols for each 
sensor. Table 1 shows the correspondence 
between each sensor and the physical channel 
implemented. 
Automated scripts were implemented to manage 
the sensor data in a transparent approach for the 
user. Host application (PP) was deployed to 
download, store and synchronize sensor data 
automatically as soon as the patient connected 
the sensor.  
2.3 Data heterogeneity: management and 
synchronization. 
The dynamic nature of the medical parameters 
gathered in the PP and the distributed 
heterogeneous data from each single sensor and 
manual record required new approaches to data 
warehousing and management. 
The central data base, contained in the system 
server, was located in a Windows Server 2008 
virtual server in Prage, CZ, separate to hospital 
networks, due to the multicenter study design 
and in order to maintain data integrity and avoid 
integration issues. The data base complied with 
the security standards on electronic medical data 
storage (ISO 27001) and privacy of data was 
ensured through dynamic encryption. 
Multi-parametric data coming from devices and 
sensors (dynamic data) was integrated in a 
centralized database. The distributed approach 
enabled dynamic information to be added, 
modified and displayed at the same time, 
individually or as a whole in each client 
application (Figure 2). Therefore, to avoid 
persistent misleading each value was assigned 
with a unique identifier allowing them to be 
distinguished in an efficient and rapid way. 
Good practices were developed to maximize 
communication data exchange and memory 
allocation and an online/offline management 
system was developed to ensure data 
synchronization.   
During the communication processes between 
medical devices, data was only transmitted 
through wireless internet connection (mobile 
network or WIFI) availability. In case of offline 
sessions, data was locally stored and sent 
whenever the connection was available. Only 
new data (no downloaded or sent previously) 
was synchronized. Integrity of data and 
synchronization has been also considered. 
Furthermore, unique identifiers for patients and 
parameters were assigned to provide a high 
integrity of data allowing re-synchronization in 
case it was needed. Automatic back-up routines 
were also implemented in the central server to 
guarantee data loss or corruption recovery. 
2.4 Evaluation 
All screened patients who fulfilled inclusion 
criteria entered a Baseline Phase of at least 3 
days (up to 6 days, based on local monitoring 
practice). The inclusion criteria for  patients was 
to be categorized for all types of diabetes and to 
have the ability to use mobile devices and 
sensors. During the Baseline Phase, patients 
recorded metabolic data on food and drug intake 
(through a paper diary), physical activity 
(through the combined use of OMRON HJ720-
IT pedometer and Sensewear-Armband), 
fingerprint glycemic values (BayerTM Contour 
Link glucometer), and continuous subcutaneous 
glucose concentration (Medtronic 
GuardianRT® Continuous Glucose Monitoring 
System). 
30 patients from three EU countries (Spain, 
Italy and Czech Republic) were planned to be 
enrolled for the trial. Up to 33 patients were 
enrolled finally, from which 3 dropped out, 
meaning 30 patients completed the trial phase. 
All patients signed an agreement and were fully 
informed about the objective of the trial. After 
the initial baseline, which consisted in a paper 
track of the monitoring parameters, patients 
were trained during a two-hour session to use 
PMD and PP to achieve the recommended goals 
for four consecutive weeks. Trial duration was 
35±6 days.  All patients were asked to monitor 
the complete set of metabolic data during the 
final 3 (6) days of the intervention phase 
(including the paper diary for food and drug 
intake). 
Four follow-up visits (V0-V3) were established 
for all subjects. The number of days between the 
chosen visits depended clinical practice in each 
country, V1-V0 was 6±2, V2-V1 was 20±4 and 
V3-V2 was 6±2. 
During trials, PMDs, PPs and services usage 
were evaluated trough the follow up of data 
increase, services consumption, exceptions rise 
and memory load (virtual and physical). 
Daemon services were enabled to record locally 
and remotely the interaction flows within 
modules and communications. To perform an 
automatized analysis, the information was 
recorded in txt files following a structured 
format. 
The ethical committee of each involved hospital 
approved the study protocol. No ethical issues 
were found prior and after the realization of the 
study. 
3 RESULTS 
Prior to trial evaluation, the system was tested in 
laboratory facilities with real devices, servers 
and switching 3G/Wi-Fi connections obtaining 
good results on time delays and performance for 
a set of benchmarked operations designated as 
critical. After these tests, the platform was 
evaluated in an international multi-center open-
label randomized study consisting of two 
groups, one intervention and other control. 
Table 2 shows a description of the group which 
completed the trial. System usefulness and 
innovative features as data aggregation, PHR 
tailoring and comprehensive view on health data 
has been evaluated through a transparent 
analysis of the components interaction, based on 
events triggered by patients. 
    Total (n=30) T1DM (n=20) T2DM-IT (n=10) 
    n % n % n % 
Gender 
Male 19 63 14 70 10 100 
Female 11 37 6 30 0 0 
Studies 
Undergraduate 3 10 3 15 1 10 
Secondary 10 33 8 40 3 30 
University 16 53 17 85 4 40 
PhD 1 3 1 5 0 0 
Marital 
Status 
Single 14 47 13 65 3 30 
Married 13 43 12 60 7 70 
Divorced 2 7 2 10 0 0 
Widowed 1 3 0 0 0 0 
Commor 
-bidities 
Infraction 0 0 0 0 0 0 
Stroke 2 7 2 10 0 0 
Renal Failure 0 0 0 0 0 0 
Liver Failure 0 0 0 0 0 0 
Lifestyle 
Smoking 9 30 4 20 5 50 
Alcohol 12 40 8 40 4 40 
Restrictive Diet 8 27 6 20 2 20 
Table 2. Study population dataset description in absolute 
and relative values divided for total population, type 1 
diabetes patients (T1DM) and type 2 diabetes patients 
(T2DM). 
The system was used during 35±6 days between 
February 2012 and September 2012 by a total 
set of 30 patients aged 45±11. Table 2 depicts 
the data set description on gender distribution, 
studies level, marital status, comorbidities and 
lifestyle. All the patients were able to perform 
measurements with the sensors and use mobile 
and desktop applications, 90% of the study 
population had secondary or higher education. 
Patients were assisted by technical staff and 
their medical practitioner during the study 
duration. 
The main purpose for the system administration, 
maintenance and performance was measured 
and evaluated under a set of Key Performance 
Indicators (KPI). A KPI is introduced as 
significant assessing criteria for system 
performance under a specific domain [22] [24] 
that may be referred by an absolute or relative 
value. For the purpose of this evaluation the 
following KPIs were addressed: total 
measurements and single entries for data 
aggregation; computational load, time delay and 
success rate for system applications 
performance. 
The assessment consisted in the analysis of 
service invocation logs, application logs and 
data base mining to evaluate the following two 
features:  
3.1 Data aggregation from multiple sensors to 
support health decisions. 
This analysis evaluates platform capability of 
aggregating data from different sensors, 
displaying them and making them available to 
health professionals preserving data integrity. 
Data has been analyzed for each patient in two 
levels; in the client application and the server 
core. Table 3 shows the number of patients 
which used each device. Through the PP 
application data was downloaded and 
aggregated in a local data base (row 3) and then 
synchronized to the server a total of 124875 
measurements. Physicians had straight access to 
server data through the CP, so that was the total 
percentage of data available to him (row 3 
shows the percentage of the patient data visible 
to health professionals). Outliers have been 
removed prior to data statistical analysis, 
meaning that only patients who used sensors 
regularly have been included. The group (n=30) 
was told to use the system to retrieve data from 
the different sensors (glucose, continuous 
monitor glucose, physical activity). 
 
Table 3. Data integrity evaluation in terms on mean and 
standard deviation for the whole trial evaluation. Sensor ID 
refers to sensors in Table 1. 
Two main families of sensors were defined, F1 
containing sensors #1,#2 and #3 for T1DM 
SENSOR ID 1 2 3 4 
Number of 
Patients 
















± 395 33± 7,7 





















patients and F2 containing #2, and #4 for 
T2DM.  
One limitation of the study is that not all the 
patients used the given sensors, as the second 
row states. The third row shows the mean and 
standard deviation of total measurements for 
each sensor and patient device. As expected, 
continuous monitors had large quantities of 
data. The variations found in sensor number 2 
are due to the fact that T1DM patients only used 
it to calibrate sensor number 1. Forth row shows 
the percentage of duplicated data (mean ± sd) 
and the fifth row the percentage of original data 
that was finally transmitted to the server, and 
thus was available to the doctor.  
3.2 Uniform access to operational tools. 
Services wrapping complex tasks in an 
automatic and user-transparent way (e.g.: sensor 
data synchronization) were been evaluated and 
analyzed. This evaluation was tackled from two 
approaches. The first focused on the access to 
remote functionalities such as web services 
invocation success, and the second on the 
performance of the applications in terms of 
memory (computational) load and time delay on 
loading the modules in which the applications 
consisted of. 











Time delay (s) 5,83 1,63 2,93 2,6 
Table 4. Application performance parameters of user 
applications: memory footprint and time delay. 
During the study, 83905 calls to web services 
were performed, from which 63% (n=53004) 
were performed by T1DM and 37% (n=30901) 
were performed by T2DM patients. Global 
service invocations distribution was 3356±2426, 
from which 4077±2853 were made by T1DM 
and 2575±1639 were done by T2DM. 
From the total of calls, a 97% (n=81294) were 
identified as 3G or WiFi connection, 64% 
(n=51814) of them were performed by T1DM 
and 36% (n=29480) were made by T2DM. 
Analysis on the type of connection showed that 
69% (n=56064) of the total of calls were carried 
out through WiFi connections and 31% 
(n=25230) by 3G. Drilling down on the type of 
connection and type of diabetes, for T1DM 
patients 71% (n=36999) were via Wifi and 29% 
(n=14815) via 3G. In T2DM, 65% (n=19065) 
used Wifi and 35% (n=10415) 3G connection, 
showing no significant differences.  
Regarding the response time, on average, the 
request delay per call was 1059 ms. For the 
iPhone it took 641 ms, and  for the  HTC was 
1303 ms, the largest requests being the ones 
related to sensor data synchronization. 
To value the reported results, the comparative 
Table 5 shows the most important features of 
the referenced studies, SMARTDIAB [17], 
PFTH [26] and METABO, the system assessed 
in this manuscript. First of all it is clear that 
there is a lack of parameters in [17] on the 
technical assessment and report of KPI 
performance. Second, a better behaviour is 
found in [26] with respect to the data 
management, even the amount of the dataset is 
not comparable (4002 single entries Vs 
124875). The unique KPI depicted in the three 
studies is the system availability, in which the 
SOA approach shows the best performance rate. 
Table 5. Comparison of the study features and reported 
KPIs. The kindness of the designed system over the 
referenced architectures is achieved by improving some of 
the KPI analyzed Time Delay, System Availability. Other 
aspects related to data integrity do not achieve the rates 
reported by [26]. 
Due to the system specifications is no possible 
to compare some of the KPI straightforward. 
For instance, it is senseless to perform a mean 
of the Measurements per Patient and compare 
the result with the value from PFTH. However, 
it can be compared to each sensor, showing that 
the diabetes system gathers around forty times 
the data of each patient for sensor 1. 
4 DISCUSSION 
Telemonitoring solutions for chronic conditions 
management are being assessed currently 
through multiple clinical [3][10] and economic 
studies[6][7]. Some of the preliminary results 
conclude that the use of these technologies is 
not related to an improvement in health 
indicators [20]. Nonetheless, other authors [25] 
point out that the use of remote monitoring 
systems has to be selective, prioritizing it for 
KPI \     
Intervention 
SMART
DIAB PFTH METABO 
Number of 
patients - 30 30 
Timespan (days) - 24.3 35±6 
Total 
Measurements - 4002 124875 
Measurements 
per Patient - 133±37 Table 3 
Duplicated Data - - 22,3% 
Data Lost - 0% 30,5% 
Maximum Time 
Delay (s) 93.33 - 2 
System 
Availability 95% 96,6% 98% 
Computational 
Load of the 
Applications 
- - Table 4 
empowered patients or who are undergoing in a 
treatment modification. 
The self-management of chronic diseases such 
as diabetes can be boosted by applying user-
friendly systems with a low error rate in 
communications and excellent performance. 
Moreover, these technologies would provide 
large amounts of temporary information to 
detect patient changes and worsening periods. 
In this paper a novel system for diabetes 
monitoring and management has been 
presented. The system has introduced two new 
concepts: the integration of different software 
environments (enabling patient specific 
interfaces to be built) through a service oriented 
architecture based and the creation of a platform 
of sensors that allows for the sharing of data, 
making it available for patients and 
professionals.  
In this system, patients have been equipped with 
mobile devices (T1DM: HTC; T2DM: iPhone 
3G), desktop applications and sensors to follow 
up their medical parameters and normal daily 
lifestyle. A set of four sensors (Medtronic 
GuardianRT, Bayer ConoturLink, Sensewear 
Armband and Omron HJ720 pedometer) has 
been integrated into the system through the 
development of a communication API.  
Furthermore, the system has been evaluated in a 
multicenter trial (n=30) during 35±6 days within 
a seven month period. The population sample 
was categorized by gender, marital status, 
academic level, presence of comorbidities and 
lifestyle. No analysis within these groups has 
been performed during this study. 
The evaluation strategy consisted on performing 
a technical evaluation of the logs registered 
during trials and data bases. The data 
aggregation from different sensors has been 
evaluated analyzing the integrity of data across 
the platform. Despite the low performance of 
sensor #3 (Table 1), a high percentage of non-
replied data from different sensors was found on 
both patient and doctor applications, pointing 
out the success on data aggregation.  
The integrity of these values on their exchange 
through the system has been assessed by 
comparing the number of entries for each 
patient and sensor. Results show that the vast 
majority of these values were correctly 
transmitted and therefore, contribute to 
highlight the quality of data in terms of integrity 
and reliability. The best performance has been 
achieved by sensor #4, revealing that a better 
level of integration (Group1 in Table 1) 
guarantees better level of data aggregation and 
integrity. The strategy of parsing values to 
string type and wrap them in ad-hoc vector 
packets stands as a good strategy to avoid data 
mismatches. Despite being from Group 2 
(Table1), sensor #3 resulted in an extremely low 
percentage of successful transmissions to the 
server (Table 3). The reason could be that in the 
high number of duplicated entries caused by this 
type of sensor, and errors in the particular logic 
of the upstream methods that should be revised 
after the evaluation (the API share methods 
within the same sensor group). In comparison to 
the results achieved by [26], the system shows a 
bad performance in Data KPIs, leading to 
conclude that more methods to guarantee a 
correct data acquisition should be implemented. 
Since the availability of the services and their 
successful transactions rate achieves a 98%, the 
problems underneath the incomplete data 
transfer are localized in the communication 
protocols with the sensors at a device level. 
Therefore, better integrity and reliability 
features (CRC checksum, logical channel 
control) should be addressed.  
Subsequently, server and application logs have 
been analyzed to evaluate uniform access to 
technical components to hide operational 
complexity. Applications had a good 
performance on each operative system and 
device, as memory footprint and delays between 
modules parameters reveal (Table 4). However, 
problems were found on T1DM application 
(running on Windows Mobile 6.5) as the 
duration of the session was increasing, thus, 
authors conclude that this operative system is 
not suitable for complex graphical resources 
management and XML exchange through web 
services. Communications used within the trial 
via web services were handled correctly with a 
98% of successful transactions, even via 3G or 
Wifi connections from all the system 
components. The average time delay is 
acceptable (<2 s). Therefore masking complex 
operations with web services in a SOA system 
has been demonstrated to have a good 
performance with respect to other architectures 
[17] [26], as Table 5 shows. 
The study does not refer to usability and user 
satisfaction metrics, which could enhance the 
quality of the result by categorizing the system 
performance towards system acceptance. The 
main limitation of the study is found in the 
sensor assignation for each type of user. Due to 
logistic issues, some sensors had to be replaced 
between the initial sets (F1 and F2) and 
therefore it has not been possible to report 
comparisons between these two groups. Another 
limitation is found on the way to measure 
security and reliability of the system. Other 
mechanisms should be added to assess in-depth 
the integrity of data, such as quality vector 
methodologies. The next step towards a full 
evaluation is to include a user satisfaction 
evaluation and clinical assessment of the 
proposed solution. 
5 CONCLUSION 
This paper has demonstrated that web services 
are suitable to build complex systems which 
integrate desktop and mobile devices and 
physiological sensors. Literature is currently 
focused on determining the cost-effectiveness of 
tele-monitoring systems without approaching a 
technical evaluation, as it done is this paper. It 
also presents a novel SOA that merges different 
types of technologies and monitoring sensors. 
This paper will help other researchers to 
perform similar evaluations, focusing on the 
same KPI, and also to enhance techniques and 
methods to evaluate the performance of remote 
monitoring systems in order to set a quantitative 
framework for assessing the performance of 
remote monitoring systems.  Future work claims 
to perform a clinical evaluation of the proposed 
system in a large study. This study should 
evaluate the impact of this system in health 
indicators such HbA1C, hospitalizations, body 
mass gain and QALY. Another field for future 
work will be adding qualitative results on user 
satisfaction and usefulness of the system. 
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